Vildagliptin vs liraglutide as a second-line therapy switched from sitagliptin-based regimens in patients with type 2 diabetes: A randomized, parallel-group study

INTRODUCTION: A step-up strategy for dipeptidyl peptidase (DPP)-4 inhibitor-based regimens has not yet been established. In addition, similarities and differences between DPP-4 inhibitors and glucagon-like peptide (GLP)-1 receptor agonists remain to be elucidated in humans. We investigated the pleio...

Descripción completa

Detalles Bibliográficos
Autores principales: Takeshita, Yumie, Takamura, Toshinari, Kita, Yuki, Otoda, Toshiki, Kato, Ken-ichiro, Wakakuri, Hitomi, Yamada, Masayuki, Misu, Hirofumi, Matsushima, Yukiko, Kaneko, Shuichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2015
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4364854/
https://www.ncbi.nlm.nih.gov/pubmed/25802727
http://dx.doi.org/10.1111/jdi.12269

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4364854/
https://www.ncbi.nlm.nih.gov/pubmed/25802727
http://dx.doi.org/10.1111/jdi.12269

Ejemplares similares